Skip to content
healthcare.dev

Ziprasidone Mesylate 20 mg/mL

NDC 72485-430, Ziprasidone Mesylate, injection, powder, lyophilized, for solution, from Armas Pharmaceuticals Inc..

Product NDC
72485-430
Status
Listed
Labeler
Armas Pharmaceuticals Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217595
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72485-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZIPRASIDONE MESYLATE20 mg/mL

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
72485-430-107248504301010 VIAL, SINGLE-DOSE in 1 CARTON (72485-430-10) / 1 mL in 1 VIAL, SINGLE-DOSE (72485-430-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5c27f0f-4e45-4bca-bb9a-2d3f1c243348

Use it

Look up 72485-430 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72485-430 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72485-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.